Profund Advisors LLC Becton Dickinson & CO Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Profund Advisors LLC holds 4,070 shares of BDX stock, worth $944,728. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,070

Previous 4,790 15.03%

Holding current value

$944,728

Previous $1.15 Million 20.02%

% of portfolio

0.03%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$220.02 - $243.75 $158,414 - $175,500	-720 Reduced 15.03%	4,070 $923,000
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $87,923 - $96,236	397 Added 9.04%	4,790 $1.15 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $6,076 - $6,646	-27 Reduced 0.61%	4,393 $1.03 Million
Q1 2024 May 08, 2024	SELL	$233.45 - $247.73 $126,529 - $134,269	-542 Reduced 10.92%	4,420 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $118,442 - $136,287	510 Added 11.46%	4,962 $1.21 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $17,843 - $19,851	70 Added 1.6%	4,452 $1.15 Million
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $26,699 - $29,715	112 Added 2.62%	4,382 $1.16 Million
Q1 2023 May 11, 2023	SELL	$229.71 - $259.35 $146,554 - $165,465	-638 Reduced 13.0%	4,270 $1.06 Million
Q4 2022 Feb 02, 2023	BUY	$218.29 - $256.91 $114,165 - $134,363	523 Added 11.93%	4,908 $1.25 Million
Q3 2022 Nov 04, 2022	SELL	$51.03 - $264.23 $16,737 - $86,667	-328 Reduced 6.96%	4,385 $977,000
Q2 2022 Aug 01, 2022	SELL	$234.74 - $275.42 $132,158 - $155,061	-563 Reduced 10.67%	4,713 $1.16 Million
Q1 2022 May 10, 2022	SELL	$243.64 - $270.48 $136,925 - $152,009	-562 Reduced 9.63%	5,276 $1.4 Million
Q4 2021 Feb 08, 2022	BUY	$230.08 - $250.94 $41,644 - $45,420	181 Added 3.2%	5,838 $1.47 Million
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $8,145 - $8,976	-35 Reduced 0.61%	5,657 $1.39 Million
Q2 2021 Aug 12, 2021	BUY	$232.65 - $254.58 $10,003 - $10,946	43 Added 0.76%	5,692 $1.38 Million
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $68,698 - $76,036	-296 Reduced 4.98%	5,649 $1.37 Million
Q4 2020 Feb 09, 2021	SELL	$221.92 - $245.94 $23,301 - $25,823	-105 Reduced 1.74%	5,945 $1.49 Million
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $346,958 - $445,030	-1,608 Reduced 21.0%	6,050 $1.41 Million
Q2 2020 Aug 03, 2020	BUY	$219.9 - $263.41 $522,482 - $625,862	2,376 Added 44.98%	7,658 $1.83 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $476,896 - $679,947	-2,437 Reduced 31.57%	5,282 $1.21 Million
Q4 2019 Feb 18, 2020	BUY	$236.45 - $266.82 $186,559 - $210,520	789 Added 11.39%	7,719 $2.1 Million
Q3 2019 Nov 12, 2019	SELL	$230.58 - $256.08 $222,740 - $247,373	-966 Reduced 12.23%	6,930 $1.75 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $400,668 - $453,525	-1,843 Reduced 18.92%	7,896 $1.99 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $179,057 - $215,659	869 Added 9.8%	9,739 $2.43 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $522,061 - $657,721	-2,550 Reduced 22.33%	8,870 $2 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $668,444 - $734,208	2,868 Added 33.54%	11,420 $2.98 Million
Q2 2018 Aug 13, 2018	SELL	$208.1 - $233.85 $196,030 - $220,286	-942 Reduced 9.92%	8,552 $2.05 Million
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $35,544 - $41,566	-173 Reduced 1.79%	9,494 $2.06 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $181,818 - $214,179	-962 Reduced 9.05%	9,667 $2.07 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $124,468 - $132,467	666 Added 6.68%	10,629 $2.08 Million
Q2 2017 Aug 11, 2017	BUY	N/A	9,963	9,963 $1.94 Million

Others Institutions Holding BDX

# of Institutions

1,809

Shares Held

260M

Call Options Held

1.27M

Put Options Held

1.09M

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $66.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Becton Dickinson & CO Transaction History